OTC - ACTIVE INGREDIENT SECTION
glycerin
glycerin
Water, Glycerin, Beta-Glucan, Butylene Glycol, Glyceryl Acrylate, Acrylic Acid Copolymer, Propylene Glycol, Dimethicone, Niacinamide, Trehalose, Dipropylene Glycol, Glycosyl trehalose, Hydrolyzed Collagen, Silkworm cocoon extract, butylene glycol/Polygonum Fagopyrum Seed Extract, Aristotelia Chilensis Fruit Extract, Phyllanthus Emblica Fruit Extract, Hippophae Rhamnoides Extract, Pueraria Thunbergiana Root Extract, Angelica Dahurica Root Extract, Saposhnikovia Divaricata Root Extract, Atractyloides Chinensis Rhizome Extract, Panax Ginseng Root Extract, Glycyrrhiza Glabra (Licorice) Root Extract, Paeonia Lactiflora Root Extract, Astragalus Membranaceus Root Extract, Cimicifuga Dahurica Root Extract, Cryptomeria Japonica Leaf Extract, Aloe Barbadensis Leaf Extract, Ligustrum Japonicum Fruit Extract, Centella asiatica extract, Panax Ginseng Root Extract, Hippophae Rhamnoides Fruit Extract, Cornus Officinalis Fruit Extract, Gynostemma Pentaphyllum Extract, Eclipta Prostrata Extract, Caulerpa Lentillifera Extract, Codium Fragile Extract, Hamamelis Virginiana (Witch Hazel) Extract, Malva Sylvestris (Mallow) Extract, Mentha Piperita (Peppermint) Leaf Extract, Veronica Officinalis Extract, Melissa Officinalis Leaf Extract, Achillea Millefolium Extract, Tremella Fuciformis (Mushroom) Extract, Donkey milk, Camel Milk, Xylitylglucoside, anhydroxylitol, xylitol, Sodium Hyaluronate, PEG-60 Hydrogenated castor oil, Caprylic/Capric Triglyceride, Hydrogenated Lecithin, Cholesterol, Octyldodecanol, Ubiquinone, Ammonium Acryloyldimethyltaurate/VP Copolymer, Tremella Fuciformis Polysaccharide, Hydroxypropyl Cyclodextrin, Thioctic acid, Potassium Hydroxide, Phenoxyethanol, Ethylhexylglycerin, Chlorphenesin, 1,2-Hexanediol, Caramel, Xanthan Gum, Adenosine, Sodium Polyacrylate, Disodium EDTA, Carbomer, Tromethamine, Lecithin, Fragrance
helps your skin anti-aging and ultimate brightening solution ampoule with moisturizing
keep out of reach of the children
apply it to face and smooth the whole face using a patting motion for absorbing well
avoid contact with eyes
discontinue use if signs of irritation appear
for external use only
| Class | Version | Type | Effective |
|---|---|---|---|
| GLYCERIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d1c9d1af-bddd-448d-86f7-69052b7d5b47 | Product name | 1 | 20220627 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 62620-1001-2 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-34fe-60a7-e053-dbdaa90a05bd | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62620-1001-1 | FEDORA Oriental Spa Ampoule | 2 mL in 1 AMPULE | LIQUID | 2 | 1 | |
| 62620-1001-2 | FEDORA Oriental Spa Ampoule | 28 in 1 PACKAGE | LIQUID | 28 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 62620-1001 | FEDORA ORIENTAL SPA AMPOULE (GLYCERIN) LIQUID [FEDORA INTERNATIONAL CO., LTD.] | 1 | Legacy NDC, 2 package rows | 20140307_73295be4-9adc-4f31-8ed9-15261d4bb99b.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| GLYCERIN | ACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| GLYCERIN | ACTIVE MOIETY | PDC6A3C0OX | 1 | |
| BETAINE | INACTIVE INGREDIENT | 3SCV180C9W | 1 | |
| BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| HYALURONATE SODIUM | INACTIVE INGREDIENT | YSE9PPT4TH | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 62620-1001 | 62620-1001-1, 62620-1001-2 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| GLYCERIN | PDC6A3C0OX | ACTIB |
| WATER | 059QF0KO0R | IACT |
| HYALURONATE SODIUM | YSE9PPT4TH | IACT |
| BUTYLENE GLYCOL | 3XUS85K0RA | IACT |
| BETAINE | 3SCV180C9W | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| BUTYLENE GLYCOL | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TRANSDERMAL | 8.12 mg | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | INJECTION, SUSPENSION / INTRAVITREAL | 23 mg | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | INJECTION, SUSPENSION / INTRA-ARTICULAR | 23 mg | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | INJECTION, SUSPENSION / INTRAMUSCULAR | 23 mg | ||
| BUTYLENE GLYCOL | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TOPICAL | 1400 mg | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | LOTION / TOPICAL | 0.01 %w/w | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | GEL / TOPICAL | 463 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 4235ae9a-79d6-4f7b-9084-571ebcb5c092 | 73295be4-9adc-4f31-8ed9-15261d4bb99b | 2014-03-06 | Warnings | 4235ae9a-79d6-4f7b-9084-571ebcb5c092 73295be4-9adc-4f31-8ed9-15261d4bb99b |
Adverse event summaries are temporarily unavailable. Other product information remains available.